New horizons from immunotherapy in malignant pleural mesothelioma

J Thorac Dis. 2018 Jan;10(Suppl 2):S322-S332. doi: 10.21037/jtd.2017.12.88.

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive disease with a severe prognosis. Medical treatment for MPM unresectable patients is still unsatisfactory; therefore novel therapeutic approaches are urgently needed. Immunotherapy represents a promising treatment for MPM patients. Here, we'll discuss the most promising immunotherapeutic treatments currently under active investigation for this still dreadful disease.

Keywords: Mesothelioma; immune-checkpoints; immunotherapy.

Publication types

  • Review